Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1007 | 943 | 1205 | 875 | 1341 | 1966 |
Fund Return | 0.68% | -5.72% | 20.47% | -4.35% | 6.04% | 7% |
Place in category | 354 | 413 | 146 | 341 | 185 | 125 |
% in Category | 80 | 92 | 21 | 88 | 57 | 51 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AllianzIncome Growth P H2EUR | 50.6B | 7.00 | -0.83 | 5.25 | ||
AllianzIncome Growth A H2EUR | 50.6B | 6.49 | -1.35 | 4.64 | ||
AllianzIncome Growth IT H2EUR | 50.6B | 7.16 | -0.68 | 5.33 | ||
AllianzIncome Growth CT H2EUR | 50.6B | 5.86 | -2.14 | 3.79 | ||
AllianzIncome Growth RT H2EUR | 50.6B | 7.03 | -0.85 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Allianz Europe Equity Growth AT EUR | 3.18B | 0.68 | -4.35 | 6.99 | ||
Allianz Europe Equity Growth P EUR | 3.18B | 1.40 | -3.53 | 7.91 | ||
Allianz Europe Equity Growth I EUR | 3.18B | 1.43 | -3.50 | 7.95 | ||
Allianz Europe Equity Growth PT EUR | 3.18B | 1.40 | -3.54 | 7.91 | ||
Allianz Europe Equity Growth IT EUR | 3.18B | 1.43 | -3.50 | 7.95 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 7.85 | 745.4 | -0.73% | |
ASML Holding | NL0010273215 | 6.87 | 652.00 | +1.54% | |
DSV | DK0060079531 | 5.51 | 1,483.5 | -1.36% | |
SAP | DE0007164600 | 4.89 | 223.500 | -1.06% | |
Sika | CH0418792922 | 3.87 | 231.20 | -0.09% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review